Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opiate antagonist in traumatic shock.

T K McIntosh, A I Faden

    Annals of Emergency Medicine
    |December 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    High-dose opiate receptor antagonists like naloxone and thyrotropin-releasing hormone (TRH) show promise in improving outcomes for traumatic shock, including hypovolemia, spinal cord, and head injuries in animal models.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    miR-711 upregulation induces neuronal cell death after traumatic brain injury.

    Cell death and differentiation·2015
    Same author

    Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death.

    Cell death & disease·2015
    Same author

    Effect of thyrotropin-releasing hormone on lipoxygenase-induced hypotension in the unanesthetized Guinea pig.

    Pharmaceutical research·2013
    Same author

    Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.

    Neuroscience·2009
    Same author

    No evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humans.

    Clinical neuropathology·2006
    Same author

    A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats.

    Neuroscience·2006

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Trauma Research

    Background:

    • Opiate receptor antagonists and TRH have demonstrated potential in experimental models of traumatic shock.
    • High doses of naloxone improve physiological variables and survival in hypovolemic, spinal, and head injury shock models.
    • The efficacy of high-dose naloxone suggests involvement of naloxone-insensitive receptors, potentially kappa-receptors, and associated ligands like dynorphin.

    Purpose of the Study:

    • To evaluate the efficacy of opiate receptor antagonists and TRH in improving outcomes following traumatic shock.
    • To explore the potential role of kappa-receptors and dynorphin in the pathophysiology of traumatic shock.
    • To assess the translational potential of these agents for clinical application in human trauma.

    Main Methods:

    Related Experiment Videos

    • Experimental animal studies utilizing models of hypovolemic shock, spinal cord trauma, and head injury.
    • Administration of high-dose naloxone and TRH or TRH analogs.
    • Assessment of physiological variables (e.g., blood pressure) and survival rates.
    • Analysis of changes in kappa-receptor ligands such as dynorphin.

    Main Results:

    • High-dose naloxone improved blood pressure and survival in various shock models.
    • TRH and its analogs also enhanced blood pressure and outcomes in hypovolemic and spinal shock.
    • Evidence suggests involvement of kappa-receptors and dynorphin in the response to traumatic injury and shock.

    Conclusions:

    • High-dose opiate antagonists, particularly those targeting kappa-receptors, and TRH show therapeutic potential for traumatic shock.
    • Further research into kappa-receptor selective antagonists may offer improved treatment strategies.
    • Clinical trials are underway or planned for naloxone and TRH in human traumatic injuries, indicating promising clinical translation.